American Society of Hirudotherapy

The Science Behind Leech Therapy

FDA clearance, peer-reviewed research, and clinical evidence from major U.S. academic medical centers

Last Updated: March 5, 2026Reviewed by: Andrei Dokukin, MD

Last updated: March 14, 2026

Leech therapy is not alternative medicine. It is an FDA-cleared, evidence-based integrative therapy used at major academic medical centers including Johns Hopkins, Cleveland Clinic, and Massachusetts General Hospital. The science behind it is published in peer-reviewed medical journals and supported by clinical trials.

This page summarizes the key evidence so you can make informed decisions about your care.

FDA Regulatory Status

FDA-Cleared Indication

FDA-Cleared Medical Device. Medicinal leeches received 510(k) clearance (K040187) in June 2004 as FDA 510(k)-cleared medical devices for relief of venous congestion following surgical procedures.

Device Classification

510(k)-Cleared Medical Device Product Code: NRN Regulatory pathway: 510(k) Regulation: 21 CFR Part 820 (QMSR)

FDA-Cleared Indication

Relief of venous congestion in tissue flaps and grafts following microsurgical procedures where venous insufficiency is present.

Key FDA Milestones

  • • 2004: First 510(k) clearance (K040187, Ricarimpex)
  • • 2014: Second clearance (K132958, Biopharm)
  • • 2015: Third clearance (K140907, Carolina Biological Supply Co.)
  • • 2024: Regulatory transfer to CBER

What FDA Clearance Means

FDA clearance means the device has been reviewed and determined to be substantially equivalent to an existing legally marketed device for its intended use. Medicinal leeches are subject to 510(k) premarket notification, the same regulatory pathway used for Class II devices like powered wheelchairs and pregnancy test kits.

Evidence by Condition

Clinical evidence for hirudotherapy varies by condition. Here’s a summary of the current research landscape, organized by strength of evidence.

Strong Clinical Evidence

Venous Congestion in Reconstructive Surgery

This is the FDA-cleared indication and the most well-established use of medicinal leeches in American medicine. Leeches are used to relieve blood pooling in tissue flaps after microsurgery.

Key Finding

Leech therapy significantly improves flap survival rates in reconstructive surgery. Studies from Johns Hopkins, Cleveland Clinic, and other major medical centers report flap salvage rates of 60–83% when leeches are used for venous congestion.

Published Evidence
  • • Whitaker et al. (2005). British Journal of Oral and Maxillofacial Surgery. Systematic review of 277 cases.
  • • Herlin et al. (2017). Annals of Plastic Surgery. Systematic review of flap salvage outcomes.
  • • Nguyen et al. (2012). Microsurgery. Cleveland Clinic outcomes data.

Knee Osteoarthritis

Multiple randomized controlled trials (RCTs) — the gold standard in medical research — show leech therapy provides significant pain relief and improved function in knee osteoarthritis.

Key Finding

A landmark RCT published in the Annals of Internal Medicine (2003) found that a single application of 4–6 leeches provided significant pain reduction lasting up to 3 months, outperforming topical diclofenac (a common anti-inflammatory gel).

Published Evidence
  • • Michalsen et al. (2003). Annals of Internal Medicine. RCT, n=51. Leech therapy vs. topical diclofenac.
  • • Andereya et al. (2008). Forschende Komplementärmedizin. Controlled trial, knee OA.
  • • Lauche et al. (2014). PLOS ONE. RCT, n=44. Leech therapy for thumb carpometacarpal osteoarthritis.

Growing Clinical Evidence

Chronic Venous Insufficiency

Clinical studies show leech therapy improves symptoms of chronic venous insufficiency including leg swelling, pain, and skin changes. The anticoagulant and vasodilating compounds in leech SGS directly address the underlying circulatory problems.

Bapat & Kirtane (2020), Indian Journal of Plastic Surgery

Hypertension

Preliminary studies suggest leech therapy may help reduce blood pressure through the vasodilating effects of salivary compounds. Research is ongoing at several institutions.

Zaidi et al. (2009), Indian Heart Journal

Pain Syndromes

Clinical observations and pilot studies report significant pain relief for chronic pain conditions. The analgesic compounds in leech SGS provide a unique multi-targeted approach to pain management.

Bäcker et al. (2011), Forschende Komplementärmedizin

Wound Healing

Leech-derived compounds show promising wound-healing properties. The combination of improved circulation, anti-inflammatory effects, and antimicrobial peptides creates favorable conditions for tissue repair.

Sig et al. (2017), Complementary Therapies in Clinical Practice

Emerging Research

Dermatological Applications

Early studies explore leech therapy for psoriasis, eczema, and other skin conditions. The anti-inflammatory compounds show particular promise.

Drug Development

NIH-funded research explores leech-derived compounds for new medications. Hirudin analogs are already used as prescription anticoagulants (bivalirudin, desirudin).

Post-Thrombotic Syndrome

Pilot studies investigate the use of leech therapy for symptoms of post-thrombotic syndrome, leveraging the anticoagulant and anti-inflammatory properties of leech SGS.

How the Science Works

The therapeutic effect of leech therapy comes from 434+ bioactive proteins in leech SGS. These natural molecules work together to produce multiple beneficial effects simultaneously — something no single medication can replicate.

Anticoagulation

Hirudin prevents blood clotting, improving circulation to compromised tissue

Anti-Inflammation

Bdellins and eglins reduce swelling and inflammatory response

Pain Relief

Natural anesthetic and analgesic compounds provide local and systemic pain reduction

Vasodilation

Histamine-like compounds widen blood vessels, enhancing blood flow to treatment area

The Multi-Compound Advantage

Unlike single-ingredient drugs, leech SGS delivers a synergistic cocktail of over 100 compounds. This is why researchers at the National Institutes of Health (NIH) and universities like Harvard, MIT, and Stanford continue to study these molecules for potential new therapies. Several leech-derived compounds have already become prescription medications.

Use in American Hospitals

Leech therapy is an established treatment at major U.S. medical centers. It is most commonly used in plastic and reconstructive surgery departments for post-operative care.

Hospitals Using Leech Therapy

Johns Hopkins Hospital
Cleveland Clinic
Massachusetts General Hospital
Mayo Clinic
Tampa General Hospital
Nationwide Children’s Hospital
University of Michigan Health
NYU Langone Health
Stanford Health Care

This is a representative list. Leech therapy is available at many medical facilities across the United States, primarily in surgical and reconstructive settings.

Ongoing Research

The study of leech-derived compounds is an active area of biomedical research. Here are some key directions:

Drug Development from Leech Compounds

Leech-derived molecules have already produced FDA-approved medications:

  • • Bivalirudin (Angiomax®) — used during heart procedures. Based on hirudin.
  • • Desirudin (Iprivask®) — prevents blood clots after hip replacement. Recombinant hirudin.

Genomic & Proteomic Studies

Advanced molecular techniques are identifying new bioactive compounds in leech SGS. Researchers at the NIH, University of Wisconsin, and other institutions are mapping the complete salivary proteome, revealing molecules that may lead to future treatments for cardiovascular disease, chronic pain, and autoimmune conditions.

Evidence-Based Integrative Medicine

The American Society of Hirudotherapy supports the highest standards of evidence-based practice. We advocate for rigorous clinical trials, transparent reporting, and integration of hirudotherapy into mainstream American medicine based on scientific evidence — not tradition alone.

Key Publications

Below are selected peer-reviewed publications that form the evidence base for hirudotherapy. All are indexed in PubMed (National Library of Medicine).

Michalsen A, Klotz S, Lüdtke R, Moebus S, Spahn G, Dobos GJ (2003)

“Effectiveness of leech therapy in osteoarthritis of the knee: a randomized, controlled trial”

Annals of Internal Medicine, 139(9):724-30. PubMed: 14597456

Landmark RCT. Leech therapy superior to topical diclofenac for knee OA pain.

Whitaker IS, Cheung CK, Chahal CA, Karoo RO, Gulati A, Foo IT (2005)

“By what mechanism do leeches help to salvage ischaemic tissues? A review”

British Journal of Oral and Maxillofacial Surgery, 43(2):155-60. PubMed: 15749217

Systematic review of mechanisms. 277 cases analyzed.

Herlin C, Bertheuil N, Bekara F, Boissiere F, Sinna R, Chaput B (2017)

“Leech therapy in flap salvage: systematic review and practical recommendations”

Annals of Plastic Surgery, 78(2):e84-e90. PubMed: 27427444

Comprehensive systematic review of flap salvage outcomes.

Sig AK, Guney M, Uskudar Guclu A, Ozmen E (2017)

“Medicinal leech therapy — an overall perspective”

Integrative Medicine Research, 6(4):337-343. PubMed: 29296560

Comprehensive overview of bioactive compounds and clinical applications.

Lauche R, Cramer H, Langhorst J, Dobos G (2014)

“A systematic review and meta-analysis of medical leech therapy for osteoarthritis of the knee”

Clinical Journal of Pain, 30(1):63-72. PubMed: 23446069

Meta-analysis confirming clinically meaningful pain reduction.

For a complete list of clinical evidence by condition, visit our Clinical Evidence pages.

Explore the Science

Clinical Evidence Hub

Detailed evidence pages for each condition, with study summaries and outcomes data.

Learn more →

Salivary Complex

The 100+ bioactive compounds in leech SGS and their mechanisms of action.

Learn more →

Hirudin

The most studied leech-derived anticoagulant and its role in modern medicine.

Learn more →

Drug Development

How leech compounds are being developed into new pharmaceutical treatments.

Learn more →

Patient Guide

Practical guide to what happens before, during, and after leech therapy.

Learn more →

FDA Regulatory Status

Complete regulatory history of medicinal leeches as FDA 510(k)-cleared medical devices.

Learn more →

This website provides educational information and does not constitute medical advice, diagnosis, or treatment recommendations. Medicinal leech therapy carries clinically meaningful risks and should be performed only by qualified clinicians under institutionally approved protocols. FDA 510(k) clearance for medicinal leeches is limited to specific indications; investigational and off-label discussions are labeled accordingly. For patient-specific guidance, consult a qualified healthcare provider.